HBM (Lux) Funds - HBM Global Biotechnology Fund A Fonds
438,34
USD
-8,22
USD
-1,84
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| argenx SE | NL0010832176 | 7,98% |
| Gilead Sciences Inc | US3755581036 | 4,75% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,14% |
| Amgen Inc | US0311621009 | 4,02% |
| Zealand Pharma AS | DK0060257814 | 3,83% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,66% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,63% |
| Insmed Inc | US4576693075 | 3,55% |
| Ascendis Pharma AS ADR | US04351P1012 | 3,54% |
| Neurocrine Biosciences Inc | US64125C1099 | 3,51% |
| Sonstige | 57,40% |